Time-Resolved Effect of Interferon-Alpha 2a on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time-Resolved Effect of Interferon-Alpha 2a on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 6, Pages 808
Publisher
MDPI AG
Online
2021-05-31
DOI
10.3390/pharmaceutics13060808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compounds
- (2021) Dirk Theile et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The aglycone diosmetin has the higher perpetrator drug-drug interaction potential compared to the parent flavone diosmin
- (2020) Gzona Bajraktari et al. Journal of Functional Foods
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
- (2017) Ruan F.V. Medrano et al. Oncotarget
- Design of Tunable Oscillatory Dynamics in a Synthetic NF-κB Signaling Circuit
- (2017) Zhi-Bo Zhang et al. Cell Systems
- Pregnane X Receptor (PXR)-Mediated Gene Repression and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator Interactions
- (2016) Petr Pavek Frontiers in Pharmacology
- Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C:a retrospective study using the Japanese Interferon Database
- (2014) Yohei Kawasaki et al. Drug Design Development and Therapy
- Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro
- (2013) Juan Pablo Rigalli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Rifampicin alters the expression of reference genes used to normalize real-time quantitative RT-PCR data
- (2013) Johanna Weiss et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells
- (2012) Johanna Weiss et al. BIOCHEMICAL PHARMACOLOGY
- Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity
- (2012) Barbara J. Brennan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Immunological Response as a Source to Variability in Drug Metabolism and Transport
- (2012) Hege Christensen et al. Frontiers in Pharmacology
- The effect of interferon-α on the expression of cytochrome P450 3A4 in human hepatoma cells
- (2011) Anathea S. Flaman et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes
- (2011) Cliff Chen et al. XENOBIOTICA
- Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
- (2010) Antonia H. Tolson et al. ADVANCED DRUG DELIVERY REVIEWS
- CYP-Mediated Therapeutic Protein-Drug Interactions
- (2010) Jang-Ik Lee et al. CLINICAL PHARMACOKINETICS
- Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics
- (2009) ET Morgan CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells
- (2009) Daisuke Yamasaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- PEG IFN alfa-2a vs. alfa-2b: And the winner is …?
- (2009) Antonio Craxì JOURNAL OF HEPATOLOGY
- Comparison of Two Immortalized Human Cell Lines to Study Nuclear Receptor-Mediated CYP3A4 Induction
- (2008) S. Harmsen et al. DRUG METABOLISM AND DISPOSITION
- Intestinal Human Colon Adenocarcinoma Cell Line LS180 Is an Excellent Model to Study Pregnane X Receptor, but Not Constitutive Androstane Receptor, Mediated CYP3A4 and Multidrug Resistance Transporter 1 Induction: Studies with Anti-Human Immunodeficiency Virus Protease Inhibitors
- (2008) A. Gupta et al. DRUG METABOLISM AND DISPOSITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now